51. 全身性強皮症 Scleroderma Clinical trials / Disease details


臨床試験数 : 523 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 113 - 標的パスウェイ数 : 214

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2000030370
2020-03-012020-02-29The efficacy and safety of sirolimus for the treatment of Systemic Sclerosis: a single-arm, single-center pilot studyThe efficacy and safety of sirolimus for the treatment of Systemic Sclerosis: a single-arm, single-center pilot study Systemic Sclerosistreatment group:sirolimus;The First Affiliated Hospital of China Medical UniversityNULLRecruiting18Bothtreatment group:20;China
2NCT03365869
(ClinicalTrials.gov)
June 1, 20184/12/2017A Pilot-Study of Sirolimus for the Treatment of Systemic SclerosisA Phase ? Pilot-Study With Sirolimus for the Treatment of Systemic SclerosisSystemic SclerosisDrug: SirolimusPeking University People's HospitalNULLNot yet recruiting18 Years80 YearsAll72Phase 2NULL
3NCT00241189
(ClinicalTrials.gov)
August 200214/10/2005Rapamycin vs Methotrexate in Diffuse SScA 48-week, Double-blind, Randomized, Parallel Phase I/II Study of Oral Rapamycin Versus Methotrexate in Systemic Sclerosis (Scleroderma)Systemic SclerosisDrug: rapamycin;Drug: methotrexateUniversity of California, Los AngelesNULLCompleted18 Years70 YearsBoth17Phase 1/Phase 2United States